Okoh A E, Umoh J U, Ezeokoli C D, Addo P B
University of Jos, Makurdi, Nigeria.
Vaccine. 1988 Feb;6(1):19-24. doi: 10.1016/0264-410x(88)90008-4.
In a preliminary study it was observed that adult ICR mice immunized with serial dilutions of an inactivated experimental human rabies vaccine from the Pitman-Moore (PM) vaccine virus were well protected against challenge with homologous virulent PM virus and challenge virus standard (CVS). However only one of five variant representatives in five of seven groups of 41 isolates of street rabies virus from Nigeria characterized by hybridoma monoclonal antibodies specific for the nucleocapsid and glycoprotein antigens of rabies virion was protected for by the vaccine. Guinea pigs immunized with a live attenuated low egg passage (LEP, Flury strain) vaccine currently used in canine vaccination in Nigeria protected against challenge with all five variants. The LEP vaccine protected against the variants and CVS quite well even when 1:125 dilution of the vaccine was used.
在一项初步研究中观察到,用来自皮特曼-摩尔(PM)疫苗病毒的灭活实验性人用狂犬病疫苗的系列稀释液免疫的成年ICR小鼠,能很好地抵御同源强毒PM病毒和攻击病毒标准株(CVS)的攻击。然而,在来自尼日利亚的41株街狂犬病毒的7组中的5组里,由针对狂犬病毒核衣壳和糖蛋白抗原的杂交瘤单克隆抗体鉴定的5个变异代表株中,只有1株受到该疫苗的保护。用尼日利亚目前用于犬类疫苗接种的减毒活低代鸡胚传代(LEP,弗吕里株)疫苗免疫的豚鼠,能抵御所有5个变异株的攻击。即使使用1:125稀释的该疫苗,LEP疫苗对变异株和CVS的防护效果也相当好。